Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP607863.RATiGk71SHqvBUn-Lq_NNXYLsk545wHoiT0yJBsLQbJ6w130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP607863.RATiGk71SHqvBUn-Lq_NNXYLsk545wHoiT0yJBsLQbJ6w130_assertion type Assertion NP607863.RATiGk71SHqvBUn-Lq_NNXYLsk545wHoiT0yJBsLQbJ6w130_head.
- NP607863.RATiGk71SHqvBUn-Lq_NNXYLsk545wHoiT0yJBsLQbJ6w130_assertion description "[We screened the transcript levels of over 8000 genes in the estrogen receptor (ERalpha) positive T-47D human breast cancer cell lines maintained at 21% O2 or 1% O2 with or without E2 co-treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP607863.RATiGk71SHqvBUn-Lq_NNXYLsk545wHoiT0yJBsLQbJ6w130_provenance.
- NP607863.RATiGk71SHqvBUn-Lq_NNXYLsk545wHoiT0yJBsLQbJ6w130_assertion evidence source_evidence_literature NP607863.RATiGk71SHqvBUn-Lq_NNXYLsk545wHoiT0yJBsLQbJ6w130_provenance.
- NP607863.RATiGk71SHqvBUn-Lq_NNXYLsk545wHoiT0yJBsLQbJ6w130_assertion SIO_000772 17475478 NP607863.RATiGk71SHqvBUn-Lq_NNXYLsk545wHoiT0yJBsLQbJ6w130_provenance.
- NP607863.RATiGk71SHqvBUn-Lq_NNXYLsk545wHoiT0yJBsLQbJ6w130_assertion wasDerivedFrom befree-2016 NP607863.RATiGk71SHqvBUn-Lq_NNXYLsk545wHoiT0yJBsLQbJ6w130_provenance.
- NP607863.RATiGk71SHqvBUn-Lq_NNXYLsk545wHoiT0yJBsLQbJ6w130_assertion wasGeneratedBy ECO_0000203 NP607863.RATiGk71SHqvBUn-Lq_NNXYLsk545wHoiT0yJBsLQbJ6w130_provenance.